This increase in the proportion of GluN2D expression was not seen in anti-psychotic-treated control brains, proving that the change was specific to schizophrenia and could not be attributed to treatment with anti-psychotics alone [128]. This evidence concerns the gene GRIN2D and schizophrenia.